<?xml version="1.0" encoding="UTF-8"?>
<p>Binding of the SARS-CoV-2 spike (S) protein to the cellular ACE2 receptor represents the first encounter (in both the endosomal and nonendosomal pathway) in the viral replication cycle and provides prophylactic intervention opportunities.
 <sup>
  <xref ref-type="bibr" rid="ref34">34</xref>
 </sup> SARS-CoV-2 spike (S) recognizes with its RBD the cellular ACE2 receptor with high affinity (
 <italic>K</italic>
 <sub>d</sub> = 14.7 nM)
 <sup>
  <xref ref-type="bibr" rid="ref12">12</xref>
 </sup> as judged by surface plasmon resonance (SPR) interaction analysis, and intervention at the RBD-ACE2 interface can potentially disrupt infection efficiency.
</p>
